Phacilitate Leaders Europe 250x

17TH - 18TH SEPTEMBER 2019


LSX has partnered with the organisers of Phacilitate Leaders Europe to offer our community of investors* free entry 17-18 September 2019 at the Royal Lancaster London.

This meeting promotes European excellence in cell and gene therapy by putting global challenges in a regional context. It is tailored to a European audience looking to commercialise ATMPs globally, as well as a global audience interested in working in and understanding the European landscape.

This is the only educational cell and gene therapy event for investors, which uncovers investment opportunities in Europe and with advanced therapies being such a young and dynamic field, understanding the commercialisation challenges is key when working out where to invest.

Why should you attend?

  • To look for investment opportunities & evaluate the latest innovations coming out of academia.
  • To meet the academic leaders from across Europe focused on advanced therapies.
  • To understand how the field will evolve in the next five years via 3 tracks: Investment & Innovation, Manufacturing & Commercialisation and Patient Access & Healthcare.

Alongside traditional plenary and roundtable sessions, there will be a dedicated partnering village to assist in successful meetings and partnerships at the event. There will also be an invite-only investment lunch, exhibition drinks, pre-event drinks and super plenary to assist in making those all-important connections.

Next steps…

If this sounds like something of interest, please contact me to find out how you can get free tickets.

Brooke Roberts
VIP Networking Manager, LSX
t: +44 (0)203 637 5908


* Free tickets are for qualifies investors only. T&Cs apply